Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO™ System Use in Conjunction With VISITAG SURPOINT™Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

NCT06324201 is registered in ClinicalTrials.gov with Heart Rhythm Clinical and Research Solutions, LLC as lead sponsor.

NCT NCT06324201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06324201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO™ System Use in Conjunction With VISITAG SURPOINT™Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation
Lead sponsor
Heart Rhythm Clinical and Research Solutions, LLC
Phase
Observational
Overall status
Recruiting
Start date
February 27, 2024
Completion date
March 31, 2028
Enrollment
250 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation